Launching April 1, 2025
One platform. Two powerful tools.
A dual-application stock market platform: Taurus for global market intelligence and research; C4Compare for comparison, ratings, portfolios, and strategy tools. One account — discover and research in Taurus, compare and decide in C4Compare.
Find stocks → compare and rate → track portfolios → backtest ideas. All in one ecosystem.
Launch in
We're live! Welcome to Taurus & C4Compare.
One login. Two apps. One flow.
Log in once and use both. Taurus is for discovery and data; C4Compare is for comparison, scoring, and decision support.
Discover & research
Screener, stock detail, indices, news, IPO, macro, options — in Taurus
Compare & rate
Up to 10 stocks, "4" rating, portfolios, themes — in C4Compare
Track & test
P&L, XIRR, backtest, beat the index — without leaving the platform
Taurus
Global market intelligence and research terminal for retail and professional investors — one place to research equities, macro, and alternatives across 50,000+ instruments and multiple markets.
What Taurus does for you
- ✓Single place for global markets — stocks, indices, sectors, ETFs, forex, crypto, commodities without switching tools.
- ✓Deep stock research — full financials, earnings, analysts, insiders, holders, dividends, and options chain.
- ✓Powerful screening — 30+ filters, presets (value, growth, dividend, momentum), and optional AI natural-language screens.
- ✓Actionable context — news with sentiment, IPO tracker, bulk/block deals, economic calendar, central bank rates.
- ✓Custom charts — multiple timeframes, candlestick/line/area, SMA, EMA, Bollinger, VWAP, RSI, MACD, export, fullscreen.
- ✓Personal workflow — watchlists, price alerts, one-click "Compare in C4Compare".
Key areas
| Area | Why it matters |
|---|---|
| Markets & stocks | One place for NSE, BSE, US, Europe, Asia. |
| Stock detail | Complete research before buying or comparing. |
| Screener | Find ideas that match your strategy. |
| Indices & sectors | Market and sector context before picking stocks. |
| IPO tracker | Track and evaluate new listings in one place. |
| News | Narrative and sentiment around markets and names. |
| Forex, crypto, commodities | Cross-asset view for macro and diversification. |
| Macro | Link macro events to portfolio decisions. |
| Options | For users who trade or hedge with options. |
| Watchlist & alerts | Stay on top of names that matter. |
Differentiators: Breadth (equities + macro + alternatives in one product). Depth (full financials, options, not just price). Screener + AI. Seamless handoff to C4Compare.
C4Compare
Stock comparison and rating platform: compare up to 10 stocks side-by-side, discover quality via the "4" rating (Valuation, Growth, Quality, Momentum), track portfolios, run thematic baskets, and backtest strategies.
What C4Compare does for you
- ✓Side-by-side comparison — up to 10 stocks: chart, metrics table, correlation, Sharpe, Sortino, drawdown, rolling returns. Export CSV, share link.
- ✓"4" rating — one score (0–100) from Valuation, Growth, Quality, Momentum. "4" tag for top names; "Almost 4" for names one step away.
- ✓Portfolio tracker — multiple portfolios, P&L, XIRR, allocation, equity curve vs benchmark, Monte Carlo, stress-test. Compare holdings in one click.
- ✓Thematic investing — curated themes (AI, EVs, pharma) plus user-created baskets with performance and "Compare All."
- ✓Strategy backtester — SMA, RSI, breakout, momentum on historical data; equity curve, CAGR, Sharpe, drawdown, trade log.
- ✓Beat the index — your basket vs Nifty 50 / S&P 500; normalized performance, alpha, beta, win rate. Tight link to Taurus for data.
Key areas
| Area | Why it matters |
|---|---|
| Compare | Make buy/skip decisions with a clear view. |
| '4' rating | Find quality ideas and see why a stock scores high or low. |
| Portfolio | Track performance and risk in one place. |
| Themes | Invest by theme without building from scratch. |
| Backtest | Test ideas before putting money in. |
| Beat the index | See if your picks beat the market. |
| Screener | Find ideas then compare and rate without leaving. |
Differentiators: Transparent \"4\" rating; compare + portfolio + backtest in one product; shareable comparisons; built for the flow with Taurus.
Research in Taurus. Compare and decide in C4Compare.
One account. Clear roles. Seamless handoffs.
From Taurus: Use \"Compare in C4Compare\" from any stock, sector, screener, or peers list to jump straight into comparison and rating.
From C4Compare: Use \"View on Taurus\" for full stock detail and charts; the screener in C4Compare uses Taurus data and can send results to Compare.
Why investors choose us
One platform, two tools — built for serious investors without a Bloomberg terminal.
By the numbers
50,000+
Stocks & instruments
10+
Markets (NSE, BSE, US, Europe, Asia…)
30+
Screener filters + AI
4
Dimensions in the "4" rating
10
Stocks in one comparison
6+
Curated themes + custom baskets
4
Backtest strategies
1
Unified account
Use cases
From finding ideas to tracking performance — all in one platform.
Find undervalued Indian pharma stocks
Taurus screener (rules or AI) → filter by sector, P/E, ROE → send to C4Compare to compare and check "4" rating.
See if my picks beat the Nifty 50
C4Compare Beat the Index: add stocks, choose Nifty 50, see chart and alpha.
One place for stocks, forex, and macro
Taurus: stocks, indices, sectors, forex, crypto, commodities, economic calendar, central bank rates.
Simple quality score before I buy
C4Compare "4" rating: see score and dimension breakdown; use "Almost 4" to find names close to the bar.
Track my portfolio and risk
C4Compare portfolio: holdings, P&L, XIRR, allocation, Monte Carlo, stress-test.
Test a strategy before real money
C4Compare backtester: pick strategy (e.g. RSI oversold), symbol, period → equity curve, CAGR, Sharpe, trades.
Built for
Retail and prosumer investors in India, US, and elsewhere who want one platform for research, comparison, rating, and portfolio — confident, clear, and action-oriented.
Get early access
First 1,000 subscribers get 6 months free. After that, we'll run a lucky draw for 500 more from the waitlist.